Technical Analysis for VYNT - Vyant Bio Inc
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Inside Day | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Gapped Down | Weakness | -9.58% | |
| Bullish Engulfing | Bullish | 2.22% | |
| New 52 Week Closing Low | Bearish | 14.13% | |
| Hot IPO Pullback | Bullish Swing Setup | 14.13% | |
| NR7 | Range Contraction | 14.13% | |
| Doji - Bullish? | Reversal | 14.13% | |
| New 52 Week Low | Weakness | 14.13% | |
| Gapped Down | Weakness | 14.13% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Possible Inside Day | 2 days ago |
| Gap Down Partially Closed | 2 days ago |
| Down 10% | 2 days ago |
| Down 5% | 2 days ago |
| Down 3% | 2 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
Vyant Bio, Inc., a biotechnology company, discovers drugs for complex neurodevelopmental and neurodegenerative disorders. The company's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. It focuses on identifying repurposed and novel small molecule clinical candidates for rare CNS genetic disorders including Rett Syndrome (Rett), CDKL5 deficiency disorders (CDD,) and familial Parkinson's disease (PD). The company is based in Cherry Hill, New Jersey.
Keywords: Biotechnology Organ Systems Drug Discovery Machine Learning Parkinson's Disease Neurological Disorders Psychiatric Diagnosis Nervous System Senescence Central Nervous System Disease Rett Syndrome Rett
Classification
Keywords: Biotechnology Organ Systems Drug Discovery Machine Learning Parkinson's Disease Neurological Disorders Psychiatric Diagnosis Nervous System Senescence Central Nervous System Disease Rett Syndrome Rett
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 0.315 |
| 52 Week Low | 0.206 |
| Average Volume | 20,320 |
| 200-Day Moving Average | 0.0000 |
| 50-Day Moving Average | 0.0000 |
| 20-Day Moving Average | 0.0000 |
| 10-Day Moving Average | 0.2383 |
| Average True Range | 0.0000 |
| RSI (14) | 0.00 |
| ADX | 0.0 |
| +DI | 0.0000 |
| -DI | 0.0000 |
| Chandelier Exit (Long, 3 ATRs) | N/A |
| Chandelier Exit (Short, 3 ATRs) | N/A |
| Upper Bollinger Bands | 0.0000 |
| Lower Bollinger Band | 0.0000 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.0000 |
| MACD Line | -0.0005 |
| MACD Signal Line | -0.0001 |
| MACD Histogram | -0.0004 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.2690 | ||||
| Resistance 3 (R3) | 0.2652 | 0.2502 | 0.2634 | ||
| Resistance 2 (R2) | 0.2502 | 0.2415 | 0.2521 | 0.2615 | |
| Resistance 1 (R1) | 0.2426 | 0.2362 | 0.2464 | 0.2464 | 0.2596 |
| Pivot Point | 0.2276 | 0.2276 | 0.2295 | 0.2295 | 0.2276 |
| Support 1 (S1) | 0.2200 | 0.2189 | 0.2238 | 0.2238 | 0.2106 |
| Support 2 (S2) | 0.2050 | 0.2136 | 0.2069 | 0.2087 | |
| Support 3 (S3) | 0.1974 | 0.2050 | 0.2069 | ||
| Support 4 (S4) | 0.2012 |
